Scinai Immunotherapeutics Stock Market Value
| SCNI Stock | USD 0.75 0.01 1.32% |
| Symbol | Scinai |
Scinai Immunotherapeutics Price To Book Ratio
Is Semiconductors & Semiconductor Equipment space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Scinai Immunotherapeuti. If investors know Scinai will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Scinai Immunotherapeuti listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.872 | Earnings Share 4 | Quarterly Revenue Growth 0.361 | Return On Assets | Return On Equity |
The market value of Scinai Immunotherapeutics is measured differently than its book value, which is the value of Scinai that is recorded on the company's balance sheet. Investors also form their own opinion of Scinai Immunotherapeuti's value that differs from its market value or its book value, called intrinsic value, which is Scinai Immunotherapeuti's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Scinai Immunotherapeuti's market value can be influenced by many factors that don't directly affect Scinai Immunotherapeuti's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Scinai Immunotherapeuti's value and its price as these two are different measures arrived at by different means. Investors typically determine if Scinai Immunotherapeuti is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Scinai Immunotherapeuti's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Scinai Immunotherapeuti 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Scinai Immunotherapeuti's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Scinai Immunotherapeuti.
| 11/24/2025 |
| 12/24/2025 |
If you would invest 0.00 in Scinai Immunotherapeuti on November 24, 2025 and sell it all today you would earn a total of 0.00 from holding Scinai Immunotherapeutics or generate 0.0% return on investment in Scinai Immunotherapeuti over 30 days. Scinai Immunotherapeuti is related to or competes with Onconetix, Scisparc, Azitra, Indaptus Therapeutics, Biomotion Sciences, Salarius Pharmaceuticals, and Jasper Therapeutics. Scanner Technologies Corporationration engages in the development and marketing of machinevision inspection solutions that are used in the semiconductor industry for the inspection of integrated circuits. More
Scinai Immunotherapeuti Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Scinai Immunotherapeuti's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Scinai Immunotherapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.12) | |||
| Maximum Drawdown | 38.82 | |||
| Value At Risk | (9.29) | |||
| Potential Upside | 10.32 |
Scinai Immunotherapeuti Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Scinai Immunotherapeuti's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Scinai Immunotherapeuti's standard deviation. In reality, there are many statistical measures that can use Scinai Immunotherapeuti historical prices to predict the future Scinai Immunotherapeuti's volatility.| Risk Adjusted Performance | (0.07) | |||
| Jensen Alpha | (0.96) | |||
| Total Risk Alpha | (1.31) | |||
| Treynor Ratio | (0.22) |
Scinai Immunotherapeutics Backtested Returns
Scinai Immunotherapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.1, which indicates the firm had a -0.1 % return per unit of risk over the last 3 months. Scinai Immunotherapeutics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Scinai Immunotherapeuti's Coefficient Of Variation of (875.00), variance of 43.1, and Risk Adjusted Performance of (0.07) to confirm the risk estimate we provide. The entity has a beta of 3.47, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Scinai Immunotherapeuti will likely underperform. At this point, Scinai Immunotherapeutics has a negative expected return of -0.68%. Please make sure to validate Scinai Immunotherapeuti's maximum drawdown, as well as the relationship between the accumulation distribution and day typical price , to decide if Scinai Immunotherapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.81 |
Excellent reverse predictability
Scinai Immunotherapeutics has excellent reverse predictability. Overlapping area represents the amount of predictability between Scinai Immunotherapeuti time series from 24th of November 2025 to 9th of December 2025 and 9th of December 2025 to 24th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Scinai Immunotherapeutics price movement. The serial correlation of -0.81 indicates that around 81.0% of current Scinai Immunotherapeuti price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.81 | |
| Spearman Rank Test | -0.88 | |
| Residual Average | 0.0 | |
| Price Variance | 0.04 |
Scinai Immunotherapeutics lagged returns against current returns
Autocorrelation, which is Scinai Immunotherapeuti stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Scinai Immunotherapeuti's stock expected returns. We can calculate the autocorrelation of Scinai Immunotherapeuti returns to help us make a trade decision. For example, suppose you find that Scinai Immunotherapeuti has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Scinai Immunotherapeuti regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Scinai Immunotherapeuti stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Scinai Immunotherapeuti stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Scinai Immunotherapeuti stock over time.
Current vs Lagged Prices |
| Timeline |
Scinai Immunotherapeuti Lagged Returns
When evaluating Scinai Immunotherapeuti's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Scinai Immunotherapeuti stock have on its future price. Scinai Immunotherapeuti autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Scinai Immunotherapeuti autocorrelation shows the relationship between Scinai Immunotherapeuti stock current value and its past values and can show if there is a momentum factor associated with investing in Scinai Immunotherapeutics.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Check out Scinai Immunotherapeuti Correlation, Scinai Immunotherapeuti Volatility and Scinai Immunotherapeuti Alpha and Beta module to complement your research on Scinai Immunotherapeuti. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Scinai Immunotherapeuti technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.